Cystatin-11 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-Cystatin11
In stock
- SKU
- REC-Cystatin11
Target Overview
Cystatin-11 is a 138-amino acid secreted protein encoded by the CST11 gene (UniProt Q9H112) and belonging to the type 2 cystatin superfamily — a family of small, disulfide-bonded cysteine protease inhibitors. This recombinant form is expressed in HEK293 cells, an expression system well-suited for mammalian proteins that benefit from human-compatible post-translational processing, correct disulfide bond formation, and native-like folding. The full-length 138-residue sequence is used unless otherwise noted in the certificate of analysis. Cystatin-11 is a secreted protein with a documented tissue-restricted expression profile, with particularly high expression in reproductive tissues including the epididymis. Its annotated functions include antibacterial activity against Gram-negative bacteria such as E. coli, and a proposed role in sperm maturation and fertilization — making it a reagent of interest in reproductive biology, innate immunity, and protease-inhibitor interaction studies. Researchers use this recombinant for several in vitro applications. As a defined, soluble antigen, it serves as a positive control or immunogen validation standard for Western blot and IHC experiments — pairing directly with the Triple Point Biologics matched antibody (catalog RP-Cystatin11) for those workflows. It is also applicable to cysteine protease inhibition assays, where its inhibitory activity against target cathepsins can be characterised kinetically. The HEK293 expression system provides material with mammalian glycosylation patterns, relevant when assessing native-like protein–protein or protein–substrate interactions. Additional uses include binding studies with epididymal luminal components and as a reference standard in proteomic or mass spectrometry experiments examining seminal or epididymal fluid composition.
Background
Applications
- Cysteine protease inhibition assay: determination of inhibitory constants (Ki) against cathepsins B, H, and L using fluorogenic substrates
- Antibody validation positive control: use as defined antigen for confirming specificity of anti-CST11 antibodies in Western blot and IHC alongside the matched Triple Point Biologics antibody (RP-Cystatin11)
- Antimicrobial activity assay: in vitro assessment of bacteriostatic or bactericidal activity against E. coli and related Gram-negative strains
- Protein–protein interaction study: pull-down or SPR-based binding experiments with epididymal luminal components or extracellular vesicle fractions
- Epididymal amyloid matrix reconstitution: in vitro assembly studies characterising CRES-subgroup cystatin incorporation into amyloid-like structures
- Proteomic reference standard: use as a spike-in or calibration standard in mass spectrometry-based quantification of seminal plasma or epididymal fluid proteomes
- Substrate selectivity profiling: competitive inhibition experiments to map protease specificity across papain-family cysteine proteases
References
- Fuentes-Albero MC et al. Protein Identification of Spermatozoa and Seminal Plasma in Bottlenose Dolphin (Tursiops truncatus). Front Cell Dev Biol. 2021. DOI: 10.3389/fcell.2021.673961. PMID: 34336830.
- Zhao W et al. Comparative RNA-Seq Analysis of Differentially Expressed Genes in the Epididymides of Yak and Cattleyak. Curr Genomics. 2019. DOI: 10.2174/1389202920666190809092819. PMID: 32030088.
- Whelly S et al. Cystatin-related epididymal spermatogenic subgroup members are part of an amyloid matrix and associated with extracellular vesicles in the mouse epididymal lumen. Mol Hum Reprod. 2016. DOI: 10.1093/molehr/gaw049. PMID: 27445316.
- Fan K et al. Expression and purification of soluble porcine cystatin 11 in Pichia pastoris. Appl Biochem Biotechnol. 2014. DOI: 10.1007/s12010-014-1148-z. PMID: 25161037.
- Frygelius J et al. The reproductive tissue specific cystatin subgroup of genes: expression during gonadal development in wildtype and testatin knockout animals. Sex Dev. 2007. DOI: 10.1159/000111768. PMID: 18391548.
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Secreted; extracellular fluids |
Frequently Asked Questions
What molecular weight does recombinant Cystatin-11 run at on SDS-PAGE or Western blot?
Cystatin-11 has a predicted molecular weight of approximately 15.8 kDa based on its 138-amino acid sequence (UniProt Q9H912). However, because this recombinant is expressed in HEK293 cells and may carry N-linked or O-linked glycosylation, the apparent MW on SDS-PAGE typically runs slightly higher — expect a band in the 17–20 kDa range under reducing conditions. Non-reducing SDS-PAGE may shift the band further due to the disulfide-bonded cystatin fold. Always confirm against your lot-specific certificate of analysis.
Is recombinant Cystatin-11 the full-length sequence or a processed/truncated form?
This preparation uses the full-length 138-residue sequence encoded by CST11 (UniProt Q9H112), expressed in HEK293 cells with a signal peptide for secretion. The secreted, mature form after signal peptide cleavage is the predominant species recovered. Cystatin-11 is a type 2 cystatin and does not undergo propeptide removal in the same manner as some papain-family inhibitors — the inhibitory wedge loop is present in the full-length mature form. Check the certificate of analysis for confirmed N-terminal sequence of your specific lot.
Which cysteine proteases does Cystatin-11 inhibit, and what substrate should I use to measure inhibitory activity?
Cystatin-11 is a type 2 cystatin superfamily member with annotated inhibitory activity toward cathepsin-family cysteine proteases, particularly cathepsin B and cathepsin L — the canonical targets for this superfamily. To measure inhibitory activity, use the fluorogenic substrate Z-Phe-Arg-AMC (typically 10–50 µM) in a cathepsin B or cathepsin L activity assay at pH 5.5–6.0, 37°C. Pre-incubate recombinant Cystatin-11 with protease for 10–15 minutes before adding substrate. IC50 values for type 2 cystatins against cathepsin B are typically in the low nanomolar range (1–10 nM); titrate Cystatin-11 from 0.1 to 100 nM to define your IC50 empirically.
What buffer conditions are recommended for Cystatin-11 activity assays, and is the storage buffer compatible?
Recombinant Cystatin-11 is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol. For inhibitory activity assays against cathepsin B or cathepsin L, you will need to dilute into a slightly acidic assay buffer — 100 mM sodium acetate, 1 mM EDTA, 2–5 mM DTT, pH 5.5–6.0 is standard. Dilute the stock at least 1:10 into assay buffer to reduce glycerol to ≤1%, which can otherwise interfere with fluorescence readings. EDTA in the assay buffer is compatible and does not affect cystatin-family inhibitors. Avoid prolonged exposure to pH below 4.5, which may destabilize the fold.
What starting concentration of recombinant Cystatin-11 should I use in a cathepsin inhibition assay?
For an initial dose-response experiment, start with a 10-point, 3-fold serial dilution ranging from 300 nM down to approximately 0.1 nM in the assay well. This range reliably brackets the expected IC50 for type 2 cystatins against cathepsin B (typically 1–10 nM). Use equimolar or sub-equimolar protease concentrations (1–5 nM cathepsin B or L) to stay within tight-binding assay conditions. If you observe a sharp sigmoidal curve compressed into fewer than 4 dilution points, reduce protease concentration. The supplied stock concentration is indicated on your lot certificate; prepare working dilutions fresh in assay buffer on the day of use.
Can I use recombinant Cystatin-11 as a positive control for Western blot with the matched Triple Point Biologics antibody?
Yes — REC-Cystatin11 is the intended positive control for the matched rabbit polyclonal antibody (SKU: RP-Cystatin11; see /anti-cystatin-11-rabbit-polyclonal-antibody). Both the recombinant protein and the antibody are produced in the same lab and validated as a pair. Load 50–200 ng of REC-Cystatin11 per lane under reducing conditions alongside your experimental lysates. Expect a band at approximately 17–20 kDa. This combination is particularly useful when validating the antibody against a tissue lysate from epididymis or other reproductive tissue, where endogenous Cystatin-11 expression is highest.
How much recombinant Cystatin-11 should I load for Western blot positive control, and will it interfere with my lysate lanes?
50–200 ng per lane is the recommended loading range when using RP-Cystatin11 (the matched antibody, SKU: RP-Cystatin11) for Western blot detection. At 100 ng, the band is reliably detected at antibody dilutions of 1:500–1:2000 without overloading. Run the recombinant control in a dedicated lane rather than spiking into lysate; at ~17–20 kDa it is unlikely to co-migrate with most proteins of interest, but its presence in a mixed lane could complicate densitometry. Because endotoxin is <0.1 EU/µg by LAL assay, the preparation is clean enough for functional cell-based assays alongside the WB control use.
How should I store and handle recombinant Cystatin-11 to maintain activity, and what is its shelf life?
Store at -20°C in the single-use aliquots provided. The supplied buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is formulated to protect activity through freeze-thaw and during short-term use. Avoid repeated freeze-thaw cycles; each cycle can cause measurable loss of inhibitory activity in disulfide-bonded proteins. Once thawed, keep on ice and use within 24 hours; do not re-freeze. Shelf life at -20°C is 12 months from the date of receipt when stored correctly. If you need to dilute to working concentrations below ~10 µg/mL, add carrier protein (0.1% BSA) to the dilution buffer to reduce adsorption losses to tube surfaces.
Validation imagery coming soon
Western blot validation figures for REC-Cystatin11 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.